Alcon (ALC) Stock Forecast & Price Target

Compare

13 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALC Analyst Ratings

Moderate Buy

9 Buy

4 Hold

1 Sell

Based on 14 analysts giving stock ratings to

Alcon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALC Stock 12 Month Forecast

Average Price Target

CHF75.73

▲(23.83% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is CHF75.73 with a high forecast of CHF95.10 and a low forecast of CHF60.06. The average price target represents a 23.83% change from the last price of CHF61.16.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"58":"CHF58","77":"CHF77","96":"CHF96","67.5":"CHF67.5","86.5":"CHF86.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95.09518445101675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF95.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.7341280696,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF75.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.060116495379,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF60.06</span>\n  </div></div>","useHTML":true}}],"tickPositions":[58,67.5,77,86.5,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.34,67.6288603423859,69.91772068477181,72.20658102715771,74.49544136954361,76.78430171192952,79.07316205431542,81.36202239670132,83.65088273908722,85.93974308147313,88.22860342385903,90.51746376624494,92.80632410863085,{"y":95.09518445101675,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.34,66.13954831304616,66.93909662609231,67.73864493913847,68.53819325218461,69.33774156523077,70.13728987827693,70.93683819132308,71.73638650436924,72.5359348174154,73.33548313046154,74.1350314435077,74.93457975655384,{"y":75.7341280696,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.34,64.93385511502916,64.5277102300583,64.12156534508746,63.71542046011662,63.30927557514577,62.903130690174926,62.496985805204076,62.090840920233234,61.684696035262384,61.27855115029154,60.87240626532069,60.46626138034985,{"y":60.060116495379,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":83.108,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.032,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.381,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.72,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.82,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.02,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.28,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.96,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.34,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF95.10

Average Price TargetCHF75.73

Lowest Price TargetCHF60.06

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graham Doyle

UBS

CHF95

Buy

55.33%

Upside

Reiterated

03/11/26

UBS Remains a Buy on Alcon (ALC)

Patrick Wood

Morgan Stanley

CHF63.16

Hold

3.28%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Skye Bioscience (NASDAQ: SKYE)

Thomas Stephan

Stifel Nicolaus

CHF63.16→CHF64.74

Hold

5.86%

Upside

Reiterated

03/09/26

Alcon price target raised to $82 from $80 at StifelAlcon price target raised to $82 from $80 at Stifel

Ryan Zimmerman

BTIG

CHF72.64

Buy

18.77%

Upside

Reiterated

03/09/26

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)

Julien Ouaddour

Bank of America Securities

CHF60

Sell

-1.90%

Downside

Reiterated

03/04/26

Alcon (ALC) Gets a Sell from Bank of America Securities

Richard Felton

Goldman Sachs

CHF74.22→CHF82.9

Buy

35.55%

Upside

Reiterated

03/04/26

Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Alcon (ALC)

Issie Kirby

Rothschild & Co Redburn

CHF77

Buy

25.90%

Upside

Reiterated

03/04/26

Rothschild & Co Redburn Keeps Their Buy Rating on Alcon (ALC)

Sam England

Berenberg Bank

CHF85

Buy

38.98%

Upside

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Jack Reynolds-Clark

RBC Capital

CHF80

Buy

30.80%

Upside

Reiterated

03/03/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Atai Beckley N.V. (NASDAQ: ATAI)

Steven Lichtman

William Blair

―

Hold

―

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (NASDAQ: MDLN), Mirum Pharmaceuticals (NASDAQ: MIRM) and Alcon (NYSE: ALC)

Matt Miksic

Barclays

CHF67.9→CHF71.06

Hold

16.19%

Upside

Reiterated

02/26/26

Alcon (ALC) Receives a Hold from Barclays

Larry Biegelsen

Wells Fargo

CHF69.48→CHF76.59

Buy

25.22%

Upside

Upgraded

02/26/26

Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC) and Alcon (NYSE: ALC)

David Saxon

Needham

CHF77.38→CHF78.96

Buy

29.10%

Upside

Reiterated

02/25/26

Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating

Falko Friedrichs

Deutsche Bank

CHF69→CHF77

Buy

25.90%

Upside

Upgraded

01/20/26

Alcon upgraded to Buy from Hold at Deutsche BankAlcon upgraded to Buy from Hold at Deutsche Bank

Veronika Dubajova

Citi

CHF91→CHF90

Buy

47.16%

Upside

Reiterated

11/28/25

Alcon price target lowered to CHF 90 from CHF 91 at CitiAlcon price target lowered to CHF 90 from CHF 91 at Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graham Doyle

UBS

CHF95

Buy

55.33%

Upside

Reiterated

03/11/26

UBS Remains a Buy on Alcon (ALC)

Patrick Wood

Morgan Stanley

CHF63.16

Hold

3.28%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Skye Bioscience (NASDAQ: SKYE)

Thomas Stephan

Stifel Nicolaus

CHF63.16→CHF64.74

Hold

5.86%

Upside

Reiterated

03/09/26

Alcon price target raised to $82 from $80 at StifelAlcon price target raised to $82 from $80 at Stifel

Ryan Zimmerman

BTIG

CHF72.64

Buy

18.77%

Upside

Reiterated

03/09/26

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)

Julien Ouaddour

Bank of America Securities

CHF60

Sell

-1.90%

Downside

Reiterated

03/04/26

Alcon (ALC) Gets a Sell from Bank of America Securities

Richard Felton

Goldman Sachs

CHF74.22→CHF82.9

Buy

35.55%

Upside

Reiterated

03/04/26

Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Alcon (ALC)

Issie Kirby

Rothschild & Co Redburn

CHF77

Buy

25.90%

Upside

Reiterated

03/04/26

Rothschild & Co Redburn Keeps Their Buy Rating on Alcon (ALC)

Sam England

Berenberg Bank

CHF85

Buy

38.98%

Upside

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Jack Reynolds-Clark

RBC Capital

CHF80

Buy

30.80%

Upside

Reiterated

03/03/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Atai Beckley N.V. (NASDAQ: ATAI)

Steven Lichtman

William Blair

―

Hold

―

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (NASDAQ: MDLN), Mirum Pharmaceuticals (NASDAQ: MIRM) and Alcon (NYSE: ALC)

Matt Miksic

Barclays

CHF67.9→CHF71.06

Hold

16.19%

Upside

Reiterated

02/26/26

Alcon (ALC) Receives a Hold from Barclays

Larry Biegelsen

Wells Fargo

CHF69.48→CHF76.59

Buy

25.22%

Upside

Upgraded

02/26/26

Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC) and Alcon (NYSE: ALC)

David Saxon

Needham

CHF77.38→CHF78.96

Buy

29.10%

Upside

Reiterated

02/25/26

Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating

Falko Friedrichs

Deutsche Bank

CHF69→CHF77

Buy

25.90%

Upside

Upgraded

01/20/26

Alcon upgraded to Buy from Hold at Deutsche BankAlcon upgraded to Buy from Hold at Deutsche Bank

Veronika Dubajova

Citi

CHF91→CHF90

Buy

47.16%

Upside

Reiterated

11/28/25

Alcon price target lowered to CHF 90 from CHF 91 at CitiAlcon price target lowered to CHF 90 from CHF 91 at Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months

xxx

Success Rate

14/21 ratings generated profit

Average Return

+2.43%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.43% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

12/21 ratings generated profit

Average Return

+2.71%

a rating ―

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.71% per trade.

2 Years

xxx

Success Rate

10/18 ratings generated profit

Average Return

+4.71%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +4.71% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALC Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALC has received 16 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. ALC average Analyst price target in the past 3 months is 75.73.

Each month's total comprises the sum of three months' worth of ratings.

ALC Financial Forecast

ALC Earnings Forecast

Next quarter’s earnings estimate for ALC is CHF0.64 with a range of CHF0.61 to CHF0.69. The previous quarter’s EPS was CHF0.60. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Sales Forecast

Next quarter’s sales forecast for ALC is CHF2.10B with a range of CHF2.05B to CHF2.17B. The previous quarter’s sales results were CHF2.17B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Stock Forecast FAQ

What is CH:ALC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alcon Inc’s 12-month average price target is 75.73.

What is CH:ALC’s upside potential, based on the analysts’ average price target?

Alcon Inc has 23.83% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Alcon Inc a Buy, Sell or Hold?

Alcon Inc has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 4 hold ratings and 1 sell ratings.

What is Alcon Inc’s share price target?

The average share price target for Alcon Inc is 75.73. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF95.10 ,and the lowest forecast is CHF60.06. The average share price target represents 23.83% Increase from the current price of CHF61.16.

What do analysts say about Alcon Inc?

Alcon Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of Alcon Inc?

To buy shares of CH:ALC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Alcon (ALC) Stock Forecast & Price Target

ALC Analyst Ratings

ALC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alcon

ALC Analyst Recommendation Trends

ALC Financial Forecast

ALC Earnings Forecast

ALC Sales Forecast

ALC Stock Forecast FAQ

Detailed List of Analyst Forecasts